Skip to main content

Find Clinical Trials

Home
Conditions
Erb-B2 Receptor Tyrosine Kinase Exon 20 Mutation

Clinical trial condition

Erb-B2 Receptor Tyrosine Kinase Exon 20 Mutation

Explore clinical trials studying Erb-B2 Receptor Tyrosine Kinase Exon 20 Mutation. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Erb-B2 Receptor Tyrosine Kinase Exon 20 Mutation trial results

Recruiting

Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC

NCT05800340

Conditions: BRAF V600 Mutation, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations: Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Guanzhou, Guangdong, China

View Trial Details